FDA Issues Warning to XanGo
XanGo executives said they haven't heard from the FDA since receiving a warning letter last summer and assume the case is closed.
Paul Teitell, the FDA's assistant district director in Denver, said the matter isn't settled. The agency can seize the product, stop the company from doing business or prosecute, he said.
"The fact they haven't heard from us since last summer doesn't mean the case is closed," Teitell responded. "We warned them, and what happens beyond that warning is based on the way they behave, not how we behave."
More Xango news
XANGO Launches 12 Days of Giving Campaign
LEHI, UT--(December 21, 2016) - XANGO, a global wellness and direct sales leader, is marking a successful 2016 by mobilizing its worldwide force of distributors for the '12 Days...
Xango President Earns Stevie Award
XANGO Global President Leslie A. Gallacher was recently selected as an Executive of the Year award winner in the 2015 Stevie Awards for Women in Business Program. Promoted to...
XANGO Launches Aeris Anti-Aging System
LAS VEGAS, NV , Sep 11, 2015 -- Global wellness and direct sales leader XANGO today at its global convention at the MGM Grand Resort & Casino launched a complete anti-aging...
Xango Names Names Ryan Anderson VP of US and Canada Markets
LEHI, UT--March 10, 2015 - XANGO, a global wellness and direct sales leader, today announced the appointment of Ryan Anderson as its new vice president of the U.S. and Canada...
XanGo Lawsuits Settle Out of Court
XanGo and a cofounder have settled lawsuits against each other. Bryan Davis, a cofounder of XanGo, sued the company in Federal court in May, alleging it defrauded him and diluted...